St. Jude Medical Center

Fullerton, California 92835

3 studies enrolling now · 28 studies all time

What they study most

ALI, ARDS, Ablation of Arrhythmia's, Acute Ischemic Stroke, Acute Lung Injury, Acute Lung Injury/Acute Respiratory Distress Syndrome (ARDS), Acute Respiratory Distress Syndrome (ARDS), Advanced Non-Small-Cell Lung Cancer, Atrial Fibrillation, Atrial Flutter, Breast Cancer, COVID

Studies at this site

• Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations — Recruiting now
• Anticoagulation in ICH Survivors for Stroke Prevention and Recovery — Recruiting now
• Machine Learning Prediction of Possible Central Line Associated Blood Stream Infections and Rate of Reduction — Recruiting now
• A Study to Assess Safety and Efficacy of PRL3-Zumab in Patients With Solid Tumors — Running, not enrolling
• Project CLEAR - Changing Lives by Eradicating Antibiotic Resistance — Completed
• Evaluate the Efficacy & Safety of Leronlimab in Patients With Severe or Critical COVID-19 — Completed
• Multi-arm Optimization of Stroke Thrombolysis — Completed
• Randomized Phase 2 Study of Atezolizumab and Entinostat in Patients With aTN Breast Cancer With Phase 1b Lead In — Completed
• A Study of Abemaciclib (LY2835219) in Women With HR+, HER2+ Locally Advanced or Metastatic Breast Cancer — Completed
• Covid-19 Infection and Pulmonary Distress Treatment With Zanubrutinib in Hospitalized Participants — Completed
• AcQMap® US Registry of Procedural and Long-term Clinical Outcomes (Discover-US) — Stopped early
• Study of Sargramostim in Patients With COVID-19 — Completed
• A Study of Ramucirumab (LY3009806) Plus Docetaxel in Participants With Urothelial Cancer — Completed
• Intravenous Aviptadil for Critical COVID-19 With Respiratory Failure — Completed
• Inhaled ZYESAMI™ (Aviptadil Acetate) for the Treatment of Severe COVID-19 — Stopped early
• A Study to Investigate Intravenous Tocilizumab in Participants With Moderate to Severe COVID-19 Pneumonia — Completed
• A Study of Nab-Paclitaxel and Gemcitabine With or Without Olaratumab (LY3012207) in Participants With Metastatic Pancreatic Cancer — Completed
• A Study of Ramucirumab (LY3009806) in Combination With Capecitabine and Cisplatin in Participants With Stomach Cancer — Completed
• A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer — Stopped early
• COMPLETE: International Acute Ischemic Stroke Registry With the Penumbra System Aspiration Including the 3D Revascularization Device — Completed
• Expanded Access Treatment Protocol: Remdesivir (RDV; GS-5734) for the Treatment of SARS-CoV2 (CoV) Infection (COVID-19) — APPROVED_FOR_MARKETING
• Trevo® Retriever Registry Post Market Surveillance — Completed
• Efficacy and Safety Study of Idelalisib in Participants With Indolent B-Cell Non-Hodgkin Lymphomas — Completed
• A Study of the Efficacy and Safety of Alteplase in Participants With Mild Stroke — Stopped early
• Clinical Evaluation of the Blazer® Open-Irrigated Catheter for Treatment of Type 1 Atrial Flutter — Completed
• Effect of Pexelizumab on All-Cause Mortality and Myocardial Infarction in Patients Undergoing Coronary Artery Bypass Graft Surgery With Cardio-Pulmonary Bypass — Completed
• A Trial of an Oral Nutritional Supplement in Older Hospitalized Patients - NOURISH Study — Completed
• Clinical Trial for Ovarian Cancer (OvaRex®) — Stopped early